sulpiride has been researched along with sincalide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crossman, AR; Graham, WC; Hill, DR; Sambrook, MA; Woodruff, GN | 1 |
Mueller, AL; Stittsworth, JD | 1 |
O'Shaughnessy, C; Poat, JA; Turnbull, MJ | 1 |
Voigt, M; Wang, RY; Westfall, TC | 1 |
Fuxe, K; Hedlund, PB; Li, XM | 1 |
Fukuchi, H; Kihira, K; Kimura, Y; Kitaura, T; Miyake, K | 1 |
Buéno, L; Del Rio-Lacheze, C; Gleïzes-Escala, C; Gué, M; Junien, JL | 1 |
Azizi, N; Rezayat, M; Zarrindast, MR | 1 |
8 other study(ies) available for sulpiride and sincalide
Article | Year |
---|---|
Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Benzodiazepinones; Cholecystokinin; Devazepide; Indicators and Reagents; Iodine Radioisotopes; Macaca fascicularis; Mazindol; Parkinson Disease, Secondary; Prosencephalon; Receptors, Cholecystokinin; Sincalide; Substantia Nigra; Succinimides; Sulpiride; Tegmentum Mesencephali; Tritium | 1991 |
Cholecystokinin octapeptide potentiates the inhibitory response mediated by D2 dopamine receptors in slices of the ventral tegmental area of the brain in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Electrophysiology; Ergolines; In Vitro Techniques; Male; Neurons; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide; Sulpiride; Tegmentum Mesencephali | 1990 |
Cyclic AMP efflux from rat striatal slices is enhanced by CCK.
Topics: Adenylyl Cyclases; Animals; Benzazepines; Cholecystokinin; Colforsin; Corpus Striatum; Cyclic AMP; Dopamine; Dopamine Antagonists; Enzyme Activation; Rats; Sincalide; Sulpiride; Vasoactive Intestinal Peptide | 1987 |
Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro.
Topics: Animals; Dopamine; In Vitro Techniques; Male; Nerve Endings; Nucleus Accumbens; Potassium; Rats; Receptors, Dopamine; Secretory Rate; Septal Nuclei; Sincalide; Sulpiride | 1986 |
Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal dopamine D2 receptors in rat forebrain sections.
Topics: Animals; Apomorphine; Autoradiography; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Nucleus Accumbens; Prosencephalon; Putamen; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sincalide; Sulpiride | 1995 |
Effects of L-dopa on cholecystokinin octapeptide tissue levels in normal and 6-hydroxydopamine-treated rat brain.
Topics: Animals; Brain Chemistry; Dopamine; Levodopa; Male; Oxidopamine; Radioimmunoassay; Rats; Rats, Wistar; Sincalide; Sulpiride | 1995 |
Reversal of CRF- and dopamine-induced stimulation of colonic motility by CCK and igmesine (JO 1784) in the rat.
Topics: Action Potentials; Animals; Benzazepines; Benzodiazepinones; Cholecystokinin; Cinnamates; Colon; Corticotropin-Releasing Hormone; Cyclopropanes; Devazepide; Dopamine; Dopamine Agents; Dopamine Antagonists; Gastrointestinal Motility; Male; Muscle, Smooth; Rats; Rats, Wistar; Sincalide; Stimulation, Chemical; Stress, Psychological; Sulpiride | 1994 |
On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.
Topics: Adrenergic Antagonists; Animals; Atropine; Benzazepines; Ceruletide; Dopamine Antagonists; Male; Methysergide; Mice; Morphine; Morphine Dependence; Movement Disorders; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Phenoxybenzamine; Pimozide; Propranolol; Receptors, Cholecystokinin; Serotonin Antagonists; Sincalide; Substance Withdrawal Syndrome; Sulpiride | 1997 |